Issue link: http://osercommunicationsgroup.uberflip.com/i/709452
C h a i n D r u g s t o r e D a i l y 6 3 S u n d a y, A u g u s t 7 , 2 0 1 6 2016 Best of Show MEET CONSUMER DESIRE FOR NUTRITION-DENSE, HEALTHY SNACKS Consumers are increasingly interested in well-being – for themselves and for their families. Today they are more aware of the connection between what they eat and their health. Snacking represents small eating moments throughout each day where consumers are faced with choices to satisfy what they need and want – both physically and emotionally. As such, peo- ple are seeking out foods that that fit their lifestyle and have better well-being cre- dentials. Mondelēz International creates snacks to bring people delicious moments of joy. To help consumers on their wellbeing journey, it knows its snacks must serve different needs. In addition to providing a delicious moment of joy, its snacks also need to help curb people's hunger or give them a nutrition- al boost. That is why, as one of the world's largest snack companies, Mondelēz International intends on becoming a leader in well-being snacks, with about half of its portfolio being a Well-being Choice by 2020. It plans to evolve its portfolio to satisfy consumers' well- being needs by making people's favorite brands better and keeping the same great taste they expect – to create snacks that can nourish the body and the soul. To realize its ambition, the company plans to expand its well-being choice offerings in its portfolio, enhance the goodness of its current brands and inspire consumers to snack mindfully, providing clear and simple nutrition information. To help achieve this, it is focusing 70 per- cent of its new product development efforts on platforms to bring new, delicious snacks to the marketplace that meet consumers' well-being needs. Well-being Choices are comprised of three types of snacks: Better Choice snacks that have an improved nutrition profile; individually-wrapped Portion Control options that are under 200 calo- ries; and Lifestyle Choice snacks that are designed to meet a specific consumer well-being need – such as being organic, allergen- or gluten-free. Portion Control and Lifestyle Choice snacks must also meet baseline nutrition criteria that the company uses to assess new products being developed, as well as guide reno- vations. At the end of 2015, 34 percent of its revenue came from Well-being Choices. The company's Well-being Snacks Goals are: deliver 25 percent of its rev- enue from Better Choices by 2020; increase Portion Control products – indi- v i d u a l l y wrapped, sat- isfying por- t i o n - c o n t r o l options that are fewer than 200 calories – by 25 per- cent by 2020; reduce sodium and saturat- ed fat by 10 percent across the portfolio by 2020; increase whole grains across its portfolio by 25 percent by 2020; and place calorie information on front of packages globally by the end of 2016. Well-being Snacks Goals are based on a 2012 baseline, which has been restat- ed due to the divestiture of its coffee busi- ness and the removal of Venezuela opera- tions from its financial reporting. For more information, view The Call for Well-being 2015 Progress Report at www .mondelezinternational.com/~/media/ MondelezCorporate/uploads/downloads /cfwbprogressreport.pdf. For more information, visit booth #2133 or call 973.503.2000. NEW PRODUCTS FROM AMNEAL IN THE PIPELINE Amneal Pharmaceuticals anticipates quite a busy second half of 2016, with several new product launches on the way. "Amneal has always invested heavi- ly – with a disproportionate percentage of its revenue – in growing and broadening our product portfolio across all dosage forms and therapeutic categories," says Jim Luce, Executive Vice President, Sales and Marketing. Since 2012, the company has focused on expanding its portfolio to include many complex dosage forms. Amneal plans to launch its first intravagi- nal product in October. This joins several new oral contraceptives to bolster the company's growing women's health product line. "Our women's health pipeline is rich with complex formulations, new dosage forms and devices dedicated to addressing specific women's health concerns," explains Luce. "We are com- mitted to expanding this category beyond 2016 and continuing to deliver high quality products and service to this patient population and its healthcare providers." The company plans to launch its first injectables product this month with sev- eral more anticipated through 2016, 2017 and beyond. Metered dosage inhalers, transdermal paches and nasal sprays will soon follow. Amneal Biosciences, a wholly- owned subsidiary focused on the institu- tional and specialty markets, will bring the injectable forms to mar- ket. "We've been strate- gically developing products across all dosage forms," adds Luce. "Injectables, both small molecules and biosimilars, are a natural extension. As we've done in both R&D and opera- tions, we've brought industry experts on board to lead the company into those markets. The Amneal Biosciences team will focus on these products, which will be distributed primarily to the institution- al segments." The company has several more high-volume/large market products in the pipeline as well. Amneal has more than 100 ANDAs pending with the U.S. Food and Drug Administration; more than a third of those are targeted to launch in the next 12 months. Roughly 40 per- cent of the pending ANDAs cover eFTF, FTM, FTF and other high-value products. The future beyond 2016 looks equally strong based on the 184 products cur- rently in development. Luce concludes, "It isn't any one part of Amneal that drives our value. It takes an entire team – the scientists, engineers, operations, logistics, sales – to create the most value for our cus- tomers. We believe by focusing on our customers and their patients, and stand- ing by the values of quality and integri- ty, this path will allow us to continue sustaining our growth for many years to come." Visit Amneal at booth #308. For more information, go to www.amneal.com.